GeneDx Holdings Corp.
NASDAQWGS cost to borrow surges 110% in one week to 0.46%, though availability remains ample at 407% of short interest.
Snapshot as of 15 Sept 2026
GeneDx Holdings has put up one of the more striking moves in the genomics space this month — up nearly 48% in 30 days and 14.5% in the past week alone to close at $87.41 — yet the short side of the ledger tells a story…
GeneDx Holdings heads into its August 4 earnings print with a notable mismatch: short interest remains heavy at nearly one-fifth of the float, yet shorts have been retreating steadily while the stock surges. The short…
GeneDx Holdings heads into its June 18 earnings report with call-side options positioning at its most aggressive in months — an unusual posture for a stock sitting on nearly 16% short interest. The bullish skew in…
GeneDx Holdings Corp. heads into its June 18 earnings date carrying two conflicting signals: its biggest institutional backers are aggressively buying the stock at post-crash prices, while short sellers are adding to a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WGS — free to start on ORTEX.
Sign up for free →Open WGS on ORTEX